Hugh Griffith - 18 Mar 2026 Form 3 Insider Report for NuCana plc (NCNA)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 17:25:16 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ian Webster, Attorney-in-Fact for Hugh Griffith

Key filing fact

Hugh Griffith filed Form 3 for NuCana plc (NCNA) on 18 Mar 2026.

Key facts

  • This page summarizes Hugh Griffith's Form 3 filing for NuCana plc (NCNA).
  • 0 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 17:25.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001296964 Primary reporting owner

Griffith Hugh

Relationship
Chief Executive Officer, Director
Address
C/O NUCANA PLC, 3 LOCHSIDE WAY, EDINBURGH, UNITED KINGDOM
Signature
/s/ Ian Webster, Attorney-in-Fact for Hugh Griffith
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NCNA holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000,000
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NCNA holding Derivative

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
52
Exercise price
Footnotes
F1
NCNA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
62,499,995
Exercise price
Footnotes
F2
NCNA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,221,867,885
Exercise price
Footnotes
F3
NCNA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,544,328,984
Exercise price
Footnotes
F4
NCNA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
691,582,704
Exercise price
Footnotes
F5
NCNA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
831,561,761
Exercise price
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each American Depositary Share ("ADS") represents 5,000 ordinary shares, nominal value 0.0004 Pounds Sterling per share (the "Ordinary Shares"), of NuCana plc (the "Company"). ADSs have no expiration date.

Footnote F2

The Ordinary Shares underlying this option have an exercise price of 0.004 Pounds Sterling, completed vesting on June 20, 2025 and expire June 20, 2035.

Footnote F3

The Ordinary Shares underlying this option have an exercise price of 0.0004 Pounds Sterling, completed vesting on June 20, 2025 and expire June 20, 2035.

Footnote F4

The Ordinary Shares underlying this option have an exercise price of 0.0004 Pounds Sterling, completed vesting on January 14, 2026 and expire January 14, 2036.

Footnote F5

The Ordinary Shares underlying this option have an exercise price of 0.0004 Pounds Sterling and will vest as to 25% on June 20, 2026, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.

Footnote F6

The Ordinary Shares underlying this option have an exercise price of 0.0004 Pounds Sterling and will vest as to 25% on January 14, 2027, with the remainder vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service with the Company through the applicable vesting date.

SEC remarks

Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .